Suppr超能文献

恶性胸膜间皮瘤患者在接受白树提取物和黑嚏根草提取物治疗后出现轻微病情缓解及长期生存(56个月)——病例报告

Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts-a case report.

作者信息

Werthmann Paul G, Saltzwedel Gerhard, Kienle Gunver S

机构信息

Institute for Applied Epistemology and Medical Methodology, Freiburg, Germany.

General Practitioner, St.-Anna-Str. 12, D-14476 Potsdam, Germany.

出版信息

J Thorac Dis. 2017 Dec;9(12):E1064-E1070. doi: 10.21037/jtd.2017.11.56.

Abstract

Malignant pleural mesothelioma (MPM) is a rare cancer with a dismal prognosis. Viscum album extracts (VAE) have strong immune stimulatory properties, cytotoxic effects, can downregulate cancer genes and inhibit angiogenesis. VAE are often used as an adjunct treatment in cancer patients but have rarely been investigated in MPM. Helleborus niger extracts (HNE) have been used in anticancer therapy since antiquity, and also show tumor specific cytotoxic effects. We present a case of a 64-year old woman with epithelioid MPM of the right chest with node involvement (T2N1M0, stage III). Deciding against the recommended radio-chemotherapy, surgery and pleurodesis, she opted for an integrative treatment approach and was treated with VAE and HNE. After 6 weeks' treatment, the pleural and nodal MPM manifestations were reduced by about 15%. Subsequent tumor growth was slow, and the patient remained in good health, enabling her to remain physically active until shortly before her death 56 months after the initial diagnosis. This is a rare case of an MPM patient not receiving any standard anticancer treatment; it still shows an extraordinary long survival and good performance status. We presume that VAE and HNE might had an impact on this clinically relevant outcome and therefore should be further investigated in MPM.

摘要

恶性胸膜间皮瘤(MPM)是一种预后不佳的罕见癌症。白树提取物(VAE)具有强大的免疫刺激特性、细胞毒性作用,可下调癌症基因并抑制血管生成。VAE常用于癌症患者的辅助治疗,但在MPM中的研究很少。黑嚏根草提取物(HNE)自古以来就被用于抗癌治疗,也显示出肿瘤特异性细胞毒性作用。我们报告一例64岁女性患者,患有右胸上皮样MPM伴淋巴结受累(T2N1M0,III期)。患者拒绝了推荐的放化疗、手术和胸膜固定术,选择了综合治疗方法,接受了VAE和HNE治疗。治疗6周后,胸膜和淋巴结MPM表现减少了约15%。随后肿瘤生长缓慢,患者健康状况良好,在初次诊断后56个月直至去世前不久都能保持身体活跃。这是一例罕见的未接受任何标准抗癌治疗的MPM患者;仍显示出超长的生存期和良好的身体状态。我们推测VAE和HNE可能对这一临床相关结果产生了影响,因此应在MPM中进一步研究。

相似文献

引用本文的文献

2
Systematic analysis of mistletoe prescriptions in clinical studies.系统分析临床研究中的槲寄生处方。
J Cancer Res Clin Oncol. 2023 Aug;149(9):5559-5571. doi: 10.1007/s00432-022-04511-2. Epub 2022 Dec 9.

本文引用的文献

1
CARE guidelines for case reports: explanation and elaboration document.病例报告的CARE指南:解释与阐述文件。
J Clin Epidemiol. 2017 Sep;89:218-235. doi: 10.1016/j.jclinepi.2017.04.026. Epub 2017 May 18.
7
Malignant pleural mesothelioma: an epidemiological perspective.恶性胸膜间皮瘤:一种流行病学视角。
Ann Cardiothorac Surg. 2012 Nov;1(4):491-6. doi: 10.3978/j.issn.2225-319X.2012.11.04.
10

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验